Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Destructive arthropathies].

J C Gerster

    La Revue Du Praticien
    |March 2, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Destructive arthropathy, seen in conditions like osteoarthritis, can progress rapidly. Factors like age and local stress contribute, but crystal deposits and common anti-inflammatory drugs show no clear link to its cause or treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    On the Training of Specialists.

    Bulletin of the New York Academy of Medicine·2009
    Same author

    [Apatite deposition diseases].

    Revue medicale suisse·2007
    Same author

    Baker cyst calcifications in a patient with rheumatoid arthritis.

    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2006
    Same author

    Periostitis in a patient with ulcerative colitis.

    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2006
    Same author

    CPPD crystal deposition disease in patients with rheumatoid arthritis.

    Clinical rheumatology·2005
    Same author

    [Reactive arthritis induced by Clostridium difficile enteritis].

    Praxis·2005

    Area of Science:

    • Rheumatology
    • Orthopedics
    • Pathology

    Context:

    • Destructive arthropathy is a significant clinical concern, presenting across various conditions including septic arthritis, inflammatory rheumatism, and osteoarthritis.
    • The rate of joint destruction can vary from slow progression to rapid deterioration.
    • Identified contributing factors include advanced age, female sex, and localized joint overload.

    Purpose:

    • To explore the underlying mechanisms and contributing factors of destructive arthropathy.
    • To evaluate the potential association of articular chondrocalcinosis and apatite deposits with destructive arthropathy.
    • To assess the clinical efficacy of intracorticosteroids and non-steroidal anti-inflammatory drugs (NSAIDs) in managing destructive arthropathy.

    Summary:

    Related Experiment Videos

  • Destructive arthropathy is observed in septic arthritis, inflammatory rheumatism, and osteoarthritis, with variable progression rates.
  • While age, sex, and local overload are implicated, clear evidence linking articular chondrocalcinosis or apatite deposits to this condition is lacking.
  • The phagocytosis of microcrystals, leading to enzymatic release, is a potential mechanism for joint destruction.
  • Current evidence does not support the routine clinical use of intracorticosteroids or NSAIDs for destructive arthropathy.

    • Impact:

    • Highlights the multifactorial nature of destructive arthropathy, extending beyond inflammatory conditions to include osteoarthritis.
    • Questions the role of crystal deposition diseases and common anti-inflammatory medications in the pathogenesis and management of destructive arthropathy.
    • Suggests further research into the enzymatic pathways involved in microcrystal-induced joint damage.